Holly Preston, NP
Family · Fort Collins, CONPI 1710474069
Payments from drug & device makers
Across 41 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$184
- AbbVie$108
- Amgen$107
- Lilly USA, LLC$73
- Biohaven Pharmaceutical Holding Company Ltd.$56
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$52
- plus $170 from 7 others
What the payments were for
- Food & beverage$751100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 9 | $184 |
| AbbVie | 6 | $108 |
| Amgen | 5 | $107 |
| Lilly USA, LLC | 5 | $73 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $56 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $52 |
| AstraZeneca | 3 | $46 |
| Astellas Pharma US Inc | 2 | $30 |
| Novo Nordisk | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| GSK | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Lundbeck LLC | 1 | $13 |
How this compares
$751 in reported general payments places this provider in the 70th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $374 |
| Levothyroxine Sodium | 26 | $286 |
| Gabapentin | 13 | $277 |
| Potassium Chloride | 13 | $218 |
| Losartan Potassium | 27 | $197 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $184 |
| Cyclobenzaprine Hcl | 16 | $184 |
| Atorvastatin Calcium | 17 | $171 |
| Doxycycline Hyclate | 18 | $151 |
| Rosuvastatin Calcium | 17 | $132 |
| Omeprazole | 12 | $128 |
| Cephalexin | 19 | $95 |
| Trazodone Hcl | 16 | $84 |
| Tramadol Hcl | 16 | $77 |
| Amlodipine Besylate | 20 | $69 |
Paid to pharmacies, not to this prescriber.
Other family in Fort Collins
- Courtney WeirFort Collins$30K
- Daphne ProvauFort Collins$22K
- Laura GrahamLakewood$1.6M
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.